# Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150)

> **NCT00652717** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 280 (actual)

## Conditions studied

- Cardiovascular Disorder

## Interventions

- **DRUG:** Ezetimibe
- **DRUG:** simvastatin

## Key facts

- **NCT ID:** NCT00652717
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02-01
- **Primary completion:** 2005-02-15
- **Final completion:** 2005-08-04
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00652717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00652717, "Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150)". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00652717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*